Mozobil Trademark Details

Mozobil was registered on Tuesday, March 24, 2009 and is currently owned by Genzyme Corporation under the registration number 3596038 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 8 years ago on Friday, October 30, 2015, according to the United State Patent & Trademark Office
Word Mark Mozobil
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Genzyme Corporation of Cambridge, MA

View all trademarks for Genzyme Corporation
Other Trademarks for Genzyme Corporation
Serial Number 77349084
Registration Number 3596038
Status Date Friday, October 30, 2015
Filing Date Friday, October 30, 2015
Registration Date Tuesday, March 24, 2009
Attorney Richard D. Allison

Correspondent

RICHARD D. ALLISON
GENZYME CORPORATION
15 PLEASANT STREET CONNECTOR
LEGAL DEPARTMENT
FRAMINGHAM, MA 01701

Case File Statements

Goods & Services Pharmaceutical and medicinal preparations for the treatment of HIV, inflammation, arthritis, asthma, cancer, cell transplants and cell transplant rejection, organ transplants and organ transplant rejection, angiogenesis, multiple sclerosis, bacterial infection, peripheral blood stem cell mobilization, cardiovascular diseases, lymphoma, tissue regeneration, tissue repair, leukemia, drug-induced anemia, retrovirus, hematopoietic deficit resulting from chemotherapy or radiation therapy, elevation of white blood cells, and ophthalmic diseases, including age related macular degeneration and diabetic retinopathy

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, October 30, 2015
First Use Anywhere Tuesday, December 30, 2008
First Use In Commerce Tuesday, December 30, 2008
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.